Alausa et al. reported that G protein subunit gamma 12 (GNG12) silencing could activate the NF-kB signaling, inhibit the PD-L1 gene transcription, promote cancer immune escape, and then activate cancer proliferation, angiogenesis and immunotherapy resistance [30]. The gene discussed is CD274; the disease is cancer.